#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Surgical treatment of diabetic retinopathy


Authors: V. Korda
Authors‘ workplace: Oční klinika Lékařské fakulty UK a FN, Hradec Králové, přednosta prof. MUDr. Pavel Rozsíval, CSc.
Published in: Vnitř Lék 2007; 53(5): 509-511
Category:

Overview

Laser treatment is effective for diabetic macular oedema and proliferative diabetic retinopathy. In focal diabetic macular oedema, laser coagulation of the microaneurisms prevents the leakage of liquid through their walls. In diffuse macular oedema, laser photocoagulation not only destroys the microaneurisms but probably also hereby causes stimulation of proliferation activity of endothelial cells in retinal capillaries and veins. For some patients with diabetic retinopathy there is a progression of retinal findings and complications arise that require surgery within the eye – pars plana vitrectomy (PPV). In general PPV is indicated in diabetic retinopathy in the following cases: vitreous opacity, traction disorders.

Key words:
diabetic retinopathy – laser panretinophotocoagulation – argon laser – diabetic macular oedema – pars plana vitrectomy


Sources

1. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabeties. Ophthalmology 1989; 96: 255-264.

2. Klein R et al. The Wisconsin Epidemiologie Study of Diabetic Retinopathy. VI. Retinal photocoagulation. Ophthalmology 1987; 94: 747-753.

3. Murphy PR, Egbert PR. Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 1979; 97: 700-702.

4. Ooft BH, Blankenship GW. Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1982; 89: 772-779.

5. Sinclair SH, Nesler C, Foxman B. Macular edema and pregnancy in insulin-dependent diabetes. Am J Ophthalmol 1984; 97: 154-167.

6. Olk RJ. Argon green (514 nm) versus krypfon red (647 nm) modified grid laser photocoagulation for diffuse Diabetic macular edema. Ophthalmology 1990; 97: 1101-1113.

7. Early Treatment Diabetic Retinopathy Study Researeh Group. Photocoagulation for diabetic macular edema. ETDRS Report No. 1. Arch Ophthalmol 1985; 103: 1796-1806.

8. Abrams GW. En bloc dissection techniques in vitrectomy for diabetic retinopathy. In: Lewis H, Ryan SJ (eds). Medical and surgical retina: advances, controversies, and management. St. Louis: Mosby; 1994: 304-320. Abrams GW, Wil1iams GA. En bloc excision of diabetic membranes. Am J Ophthalmol 1987; 103: 302.

9. McLeod D. Entry site neovascularization after diabetic vitrectomy. Br J Ophthalmol 2000; 84: 810-811.

10. Eliott O Outcome of vitrectomy for dense, premacular, subhyaloid hemorrhage secondary to proliferative diabetie retinopathy. In: Retina Society/Vitreous Society annual meeting - the combined meeting. San Francisco, CA: 2002.

11. Steinberg PJ, Aguilar HE, Drews C et al. The effect of tissue plasminogen activator on retinal bleeding. Arch Ophthalmol 1990; 108: 720.

Labels
Diabetology Endocrinology Internal medicine

Article was published in

Internal Medicine

Issue 5

2007 Issue 5

Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#